Faculty of Health, Department of Medicine, Angers, France.
Department of Biostatistics, La Maison de la Recherche, Angers University Hospital, 4 rue Larrey, 49933, Angers Cedex 9, France.
Sci Rep. 2021 Apr 1;11(1):7423. doi: 10.1038/s41598-021-86699-w.
Despite a significant improvement with enhanced recovery programmes (ERP), gastro-intestinal (GI) functions that are impaired after colorectal resection and postoperative ileus (POI) remain a significant issue. In the literature, there is little evidence of the distinction between the treatment assessed within or outside ERP. The purpose was to evaluate the efficiency of treatments to reduce POI and improve GI function recovery within ERP. A search was performed in PubMed and Scopus on 20 September 2019. The studies were included if they compared the effect of the administration of a treatment aiming to treat or prevent POI or improve the early functional outcomes of colorectal surgery within an ERP. The main outcome measures were the occurrence of postoperative ileus, time to first flatus and time to first bowel movement. Treatments that were assessed at least three times were included in a meta-analysis. Among the analysed studies, 28 met the eligibility criteria. Six of them focused on chewing-gum and were only randomized controlled trials (RCT) and 8 of them focused on Alvimopan but none of them were RCT. The other measures were assessed in less than 3 studies over RCTs (n = 11) or retrospective studies (n = 2). In the meta-analysis, chewing gum had no significant effect on the endpoints and Alvimopan allowed a significant reduction of the occurrence of POI. Chewing-gum was not effective on GI function recovery in ERP but Alvimopan and the other measures were not sufficiently studies to draw conclusion. Randomised controlled trials are needed.Systematic review registration number CRD42020167339.
尽管强化康复方案 (ERP) 有了显著的改善,但结直肠切除术后和术后肠梗阻 (POI) 导致的胃肠道 (GI) 功能受损仍然是一个重大问题。在文献中,很少有证据表明在 ERP 内或外评估的治疗之间存在区别。目的是评估治疗 POI 和改善 GI 功能恢复的治疗方法在 ERP 中的效率。2019 年 9 月 20 日,在 PubMed 和 Scopus 上进行了检索。如果研究比较了旨在治疗或预防 POI 或改善结直肠手术后早期功能结果的治疗药物的效果,则将其纳入研究。主要观察指标是术后肠梗阻的发生、首次排气时间和首次排便时间。至少评估 3 次的治疗方法被纳入荟萃分析。在分析的研究中,有 28 项符合入选标准。其中 6 项研究集中在咀嚼口香糖上,且均为随机对照试验 (RCT),8 项研究集中在 Alvimopan 上,但均不是 RCT。其他措施在 RCT(n=11)或回顾性研究(n=2)中评估的研究少于 3 项。荟萃分析中,咀嚼口香糖对终点没有显著影响,而 Alvimopan 可显著降低 POI 的发生。在 ERP 中,咀嚼口香糖对 GI 功能恢复没有效果,但 Alvimopan 和其他措施的研究还不够充分,无法得出结论。需要进行随机对照试验。系统评价注册号 CRD42020167339。